JOURNAL OF INFECTIOUS DISEASES, cilt.221, sa.3, ss.356-366, 2020 (SCI-Expanded)
Background. The effect of neuraminidase inhibitor (NAI) treatment on length of stay (LoS) in patients hospitalized with influenza is unclear.